Radiation therapy is one of the most significant cancer
treatments. It is often prescribed in combination with chemotherapy and/or
surgery for the maximum effectiveness. Radiotherapy focuses on destroying
cancer cells and increasing life expectancy of the patients. High prevalence of
cancer may boost applications of this therapy. Moreover, technological
advancements are anticipated to influence adoption of radiation oncology as the
primary treatment of cancer.
Innovative delivery methods of radiotherapy are anticipated
to improve effectiveness & safety. Major companies focus on introducing
novel radiation technologies. Some of these techniques are already in use,
while others need further research & study before they are approved for
general usage.
Hyperthermia:
This treatment utilizes heat for the treatment of different
types of cancer. Heat is helpful for removing cancer cells. However, it is not
too effective when used without any supplementary therapy. Currently,
researchers are studying the heat generated by ultrasound & microwaves to
determine its effectiveness with radiation oncology. This can improve the
results of the radiation therapy in the near future.
Hyperbaric
Oxygen Therapy (HBOT):
It involves breathing pure & clean oxygen under
controlled surroundings. HBOT is carried out in a chamber that is sealed and
pressurized at 1½ to 3 times the usual atmospheric pressure. These conditions
can improve the sensitivity & response of certain types of cancer to
radiation. Research & development for HBOT can put more light on the
effects of this therapy in reversing the damage caused to the healthy body
tissues during radiation.
Radioprotectors:
These substances can protect healthy tissues from the
harmful effects of radiation. These drugs can protect normal cells from neck
and head from exposure to radiation. Amifostine (Ethyol), a common
radioprotector, is already being used along with radiotherapy.
Market
Insights:
According to Grand View Research, Inc.; the global radiation
oncology market is anticipated to grow at a
substantial CAGR during the forecast period (2014 to 2025). Rapid technological
developments, high healthcare expenditure, and preference for radiotherapy as
the primary treatment can propel market growth. Nordion (Canada) Inc.; IsoRay,
Inc.; Elekta AB; and Mallinckrodt Public Ltd. Company are some of the chief
companies operating in the market.
In-Depth
research report on radiation oncology market :
No comments:
Post a Comment